Multiscale Modeling of Drug-induced Effects of ReDuNing Injection on Human Disease: From Drug Molecules to Clinical Symptoms of Disease

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Luo, Fang ^a   Gu, Jiangyong ^a   Zhang, Xinzhuang ^b   Chen, Lirong ^a   Cao, Liang ^b   Li, Na ^b   Wang, Zhenzhong ^b   Xiao, Wei ^b   Xu, Xiaojie ^a  

^a PEKING UNIVERSITY   (China)

^b Institute of Traditional Chinese Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; HERBACEOUS AGENT; REDUNING;

CHINESE MEDICINE; HUMAN; INFLUENZA, HUMAN; MOLECULAR DOCKING; PNEUMONIA; TUBERCULOSIS, PULMONARY;

ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; DRUGS, CHINESE HERBAL; HUMANS; INFLUENZA, HUMAN; MEDICINE, CHINESE TRADITIONAL; MOLECULAR DOCKING SIMULATION; PNEUMONIA; TUBERCULOSIS, PULMONARY;

EID: 84929379871     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10064     Document Type: Article

References (63)

1. Ji, H. F., Li, X. J. & Zhang, H. Y. Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia? EMBO Rep. 10, 194-200, (2009).
2. Yang, X. et al. Identifying the Zheng in psoriatic patients based on latent class analysis of traditional Chinese medicine symptoms and signs. Chin. Med. 9, 1, (2014).
3. Li, J. et al. Synergism and rules from combination of Baicalin, Jasminoidin and Desoxycholic acid in refined Qing Kai Ling for treat ischemic stroke mice model. PLoS One 7, e45811, (2012).
4. Liu, X. & Guo, D. A. Application of proteomics in the mechanistic study of traditional Chinese medicine. Biochem. Soc. Trans. 39, 1348-1352, (2011).
5. Zhang, A. et al. Metabolomics: towards understanding traditional Chinese medicine. Planta Med. 76, 2026-2035, (2010).
6. Liang, X., Li, H. & Li, S. A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. Mol. BioSyst. 10, 1014-1022, (2014).
7. Li, S. [Framework and practice of network-based studies for Chinese herbal formula]. Zhong Xi Yi Jie He Xue Bao 5, 489-493, (2007).
8. Li, S. & Zhang, B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin. J. Nat. Med. 11, 110-120, (2013).
9. Zhang, B., Wang, X. & Li, S. An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula, Qing-Luo-Yin. Evid. Based Complement. Alternat. Med. 2013, 456747, (2013).
10. Zhao, J., Jiang, P. & Zhang, W. Molecular networks for the study of TCM pharmacology. Brief. Bioinform. 11, 417-430, (2010).
11. Vicini, P. Multiscale modeling in drug discovery and development: future opportunities and present challenges. Clin. Pharmacol. Ther. 88, 126-129, (2010).
12. Cui, M., Li, H. & Hu, X. Similarities between "Big Data" and traditional Chinese medicine information. J. Tradit. Chin. Med. 34, 518-522, (2014).
13. Li, G., Zuo, X. & Liu, B. Scientific computation of big data in real-world clinical research. Front. Med. 8, 310-315, (2014).
14. Wang, Y. C., Deng, N., Chen, S. & Wang, Y. Computational Study of Drugs by Integrating Omics Data with Kernel Methods. Molecular Informatics 32, 930-941, (2013).
15. Wang, L., Wang, Y., Hu, Q. & Li, S. Systematic analysis of new drug indications by drug-gene-disease coherent subnetworks. CPT Pharmacometrics Syst. Pharmacol. 3, e146, (2014).
16. Lamb, J. The Connectivity Map: a new tool for biomedical research. Nat. Rev. Cancer 7, 54-60, (2007).
17. Tang, L. P. et al. Anti-inflammatory effects of Reduning Injection on lipopolysaccharide-induced acute lung injury of rats. Chin. J. Integr. Med. 20, 591-599, (2014).
18. Shang, X., Pan, H., Li, M., Miao, X. & Ding, H. Lonicera japonica Thunb.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J. Ethnopharmacol. 138, 1-21, (2011).
19. Deng, Y. et al. Geniposide inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. Int. Immunopharmacol. 17, 561-567, (2013).
20. Li, T. et al. Anti-inflammatory and immunomodulatory mechanisms of artemisinin on contact hypersensitivity. Int. Immunopharmacol. 12, 144-150, (2012).
21. Zu, M., Zhou, D., Gao, L., Liu, A. L. & Du, G. H. [Evaluation of Chinese traditional patent medicines against influenza virus in vitro]. Yao Xue Xue Bao 45, 408-412, (2010).
22. Gao, W., Wang, S., Cui, Z., Cao, J. & Tian, H. [Reduning injection for community-acquired pneumonia: meta-analysis]. Zhongguo Zhong Yao Za Zhi 36, 3539-3543, (2011).
23. Zuo, L., Chen, Y. & Zhang, W. [Reduning injection inhibits replication and proliferation of mouse cytomegalovirus and down-regulates the expressions of IFN-gamma and IL-6 in mouse cytomegalovirus pneumonia]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 29, 1242-1244, (2013).
24. Zhang, G. et al. Reduning injection for fever, rash, and ulcers in children with mild hand, foot, and mouth disease: a randomized controlled clinical study. J. Tradit. Chin. Med. 33, 733-742, (2013).
25. Li, Y. et al. Screening and analyzing the potential bioactive components from reduning injection, using macrophage cell extraction and ultra-high performance liquid chromatography coupled with mass spectrometry. Am. J. Chin. Med. 41, 221-229, (2013).
26. Zhang, X. et al. Network pharmacology study on the mechanism of traditional Chinese medicine for upper respiratory tract infection. Mol. BioSyst. 10, 2517-2525, (2014).
27. Chang, Y. X. et al. The activity-integrated method for quality assessment of reduning injection by on-line DPPH-CE-DAD. PLoS One 9, e106254, (2014).
28. Yang, H. et al. A novel systems pharmacology model for herbal medicine injection: a case using reduning injection. BMC Complement. Altern. Med. 14, 430, (2014).
29. Sheiner, L. B. Learning versus confirming in clinical drug development. Clin. Pharmacol. Ther. 61, 275-291, (1997).
30. Woodcock, J. & Woosley, R. The FDA critical path initiative and its influence on new drug development. Annu. Rev. Med. 59, 1-12, (2008).
31. White, N. J. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41, 1413-1422, (1997).
32. Kang, O. H., Choi, J. G., Lee, J. H. & Kwon, D. Y. Luteolin isolated from the flowers of Lonicera japonica suppresses inflammatory mediator release by blocking NF-kappaB and MAPKs activation pathways in HMC-1 cells. Molecules 15, 385-398, (2010).
33. Ulubelen, A., Miski, M., Neuman, P. & Mabry, T. J. Flavonoids of Salvia tomentosa (Labiatae). J. Nat. Prod. 42, 261-263, (1979).
34. Seelinger, G., Merfort, I., Wolfle, U. & Schempp, C. M. Anti-carcinogenic effects of the flavonoid luteolin. Molecules 13, 2628-2651, (2008).
35. Seelinger, G., Merfort, I. & Schempp, C. M. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med. 74, 1667-1677, (2008).
36. Lin, Y., Shi, R., Wang, X. & Shen, H. M. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr. Cancer Drug Targets 8, 634-646, (2008).
37. Tang, L. P. et al. [Study on antipyretic effect of Reduning injection on lipopolysaccharide-induced fever rats]. Zhongguo Zhong Yao Za Zhi 38, 2374-2377, (2013).
38. Kim, J. S., Kwon, C. S. & Son, K. H. Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid. Biosci. Biotechnol. Biochem. 64, 2458-2461, (2000).
39. Tadera, K., Minami, Y., Takamatsu, K. & Matsuoka, T. Inhibition of alpha-glucosidase and alpha-amylase by flavonoids. J. Nutr. Sci. Vitaminol. (Tokyo) 52, 149-153, (2006).
40. Zhou, X., Menche, J., Barabasi, A. L. & Sharma, A. Human symptoms-disease network. Nat. Commun. 5, 4212, (2014).
41. Li, S. et al. Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. IET Syst. Biol. 1, 51-60, (2007).
42. Kanawong, R. et al. Automated Tongue Feature Extraction for ZHENG Classification in Traditional Chinese Medicine. Evid. Based Complement. Alternat. Med. 2012, 912852, (2012).
43. Lawn, S. D. & Zumla, A. I. Tuberculosis. Lancet 378, 57-72, (2011).
44. Eccles, R. Understanding the symptoms of the common cold and influenza. Lancet Infect. Dis. 5, 718-725, (2005).
45. Tang, L.-P. et al. ReDuNing, a patented Chinese medicine, reduces the susceptibility to H1N1 influenza of mice loaded with restraint stress. Eur. J. Integr. Med. 6, 637-645, (2014).
46. Hsieh, C. S. et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547-549, (1993).
47. Gately, M. K. et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16, 495-521, (1998).
48. Paval, J. et al. Anti-arthritic potential of the plant Justicia gendarussa Burm F. Clinics (Sao Paulo) 64, 357-362, (2009).
49. Shukla, S., Fu, P. & Gupta, S. Apigenin induces apoptosis by targeting inhibitor of apoptosis proteins and Ku70-Bax interaction in prostate cancer. Apoptosis 19, 883-894, (2014).
50. Kasala, E. R. et al. Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives. Toxicol. Lett. 233, 214-225, (2015).
51. Gu, J. et al. Use of natural products as chemical library for drug discovery and network pharmacology. PLoS One 8, e62839, (2013).
52. Li, H. Studies on Pharmacodynamic Material Basis of Redlining Injection, PhD thesis, Nanjing University of Chinese Medicine, (2013).
53. Berman, H. M. et al. The Protein Data Bank. Nucleic Acids Res. 28, 235-242, (2000).
54. Luo, F., Gu, J., Chen, L. & Xu, X. Systems pharmacology strategies for anticancer drug discovery based on natural products. Mol. BioSyst. 10, 1912-1917, (2014).
55. Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785-2791, (2009).
56. Jiang, X., Kumar, K., Hu, X., Wallqvist, A. & Reifman, J. DOVIS 2.0: an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0. Chem. Cent. J. 2, 18, (2008).
57. Gu, J., Luo, F., Chen, L., Yuan, G. & Xu, X. A systematic study of chemogenomics of carbohydrates. Mol. BioSyst. 10, 391-397, (2014).
58. Ogata, H. et al. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 27, 29-34, (1999).
59. Saito, R. et al. A travel guide to Cytoscape plugins. Nat. Methods 9, 1069-1076, (2012).
60. Pujol, A., Mosca, R., Farres, J. & Aloy, P. Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol. Sci. 31, 115-123, (2010).
61. Aguilera, M. et al. Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population. Psychol. Med. 39, 1425-1432, (2009).
62. Costigan, M. & Woolf, C. J. Pain: molecular mechanisms. J. Pain 1, 35-44, (2000).
63. Jeunemaitre, X. et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 71, 169-180, (1992).